U.S. Navy Increases Contract Award for Sarcos Guardian® DX Highly Dexterous Mobile Robotic Avatar System
Sarcos Defense has announced that the U.S. Navy exercised a contract option to expand testing and evaluation of the Guardian DX robotic system for Navy-specific tasks. This system focuses on enhancing maintenance and modernization efforts. The Guardian DX is designed for teleoperation, providing human-like dexterity in challenging conditions. Tom Jackson, President of Sarcos Defense, emphasized the significance of this contract in supporting the Navy's readiness and modernization priorities. The initiative aligns with Sarcos' aim to commercialize the Guardian DX in line with Navy requirements.
- U.S. Navy exercising contract option indicates strong demand for Guardian DX robotic system.
- Guardian DX addresses Navy's maintenance and modernization requirements, potentially increasing future contracts.
- Tom Jackson's statement reflects a commitment to innovation and cost-effective solutions.
- None.
Following successful execution of the first phase of the Guardian DX contract, the U.S. Navy has exercised a contractual option to expand testing, evaluation, and demonstrations for Navy-specific tasks
SALT LAKE CITY, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Sarcos Defense, a wholly-owned subsidiary of Sarcos Technology and Robotics Corporation (“Sarcos”), a leader in the development of robots that augment humans to enhance productivity and safety, today announced that the U.S. Navy has exercised a contractual option to expand testing, evaluation, and demonstrations of the Guardian® DX teleoperated dexterous robotic system for Navy-specific tasks, with a focus on the Navy’s maintenance, modernization, and sustainment requirements.
The Guardian DX robot is the defense-specific variant of the Guardian® XT™ highly dexterous mobile robotic system, which itself is a variant of the award-winning Sarcos Guardian® XO® full-body, battery-powered industrial exoskeleton. The Guardian DX robot is a teleoperated, dual-armed dexterous robot designed to perform tasks with human-like dexterity while keeping the operator at a safe distance in challenging and hazardous conditions, including at height. Its modular design enables the Guardian DX robot to be mounted to a variety of mobile bases.
“Consistent with the Chief of Naval Operations’ readiness and modernization priorities announced earlier this year, we couldn’t be more proud to partner with the U.S. Navy to deliver innovative and cost-effective solutions to enhance our nation’s readiness at sea,” said Tom Jackson, President, Sarcos Defense. “The Navy’s exercise of this contract option is an important step in our efforts to commercialize the Guardian DX consistent with the Navy’s requirements.”
For more information on Sarcos Defense and the Guardian DX robotic system, please visit https://www.sarcos.com/defense or https://www.sarcos.com/guardian-dx.
About Sarcos Defense
Sarcos Defense, based in Salt Lake City, Utah, is a wholly-owned subsidiary of Sarcos Technology and Robotics Corporation, a leader in robotic systems that augment humans to enhance productivity and safety. Sarcos Defense is led by an elite team of proven retired U.S. military officers who understand the current and future threat environment and are uniquely equipped to deliver solutions that meet the needs of the modern military. Working closely with the U.S. Department of Defense and other federal and international government agencies, Sarcos Defense identifies capability gaps and undertakes research and development efforts, as well as rapid systems integration, to transform Sarcos’ commercial products into specialized, mission-ready solutions that meet the specified requirements. For more information, please visit www.sarcos.com/defense.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, Sarcos’ product roadmap, including the expected timing of commercialization or new product releases, Sarcos’ plans to expand its product availability and Sarcos’ use of capital, including Sarcos’ ability to accomplish the initiatives outlined above. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. These statements may be preceded by, followed by, or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates,” “intends” or “continue” or similar expressions. Such forward-looking statements involve risks and uncertainties that may cause actual events, results or performance to differ materially from those indicated by such statements. These forward-looking statements are based on Sarcos’ management’s current expectations and beliefs, as well as a number of assumptions concerning future events. However, there can be no assurance that the events, results, or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made, and Sarcos is not under any obligation and expressly disclaims any obligation, to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports, which Sarcos has filed or will file from time to time with the SEC. In addition to factors previously disclosed in Sarcos’ reports filed with the SEC and those identified in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: Sarcos’ ability to execute on its business strategy, address supply chain disruptions, launch its products within expected timelines, develop new products and services and enhance existing products and services; ability to respond rapidly to emerging technology trends; ability to compete effectively, recruit and retain qualified personnel and manage growth and costs; and other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Sarcos’ definitive proxy statement filed with the SEC on August 6, 2021 and other documents of Sarcos filed, or to be filed, with SEC. The documents filed by Sarcos with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov.
FAQ
What is the Guardian DX robotic system?
What contract option did the U.S. Navy exercise with Sarcos?
How does the Guardian DX support the U.S. Navy?
What company is Sarcos Defense a subsidiary of?
When was the contract option for Guardian DX announced?
